ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,540, issued on July 14, was assigned to Beijing Biosis Healing Biological Technology Co. Ltd. (Beijing).
"Chimeric peptide-modified SIS membrane, preparation method therefor and application thereof" was invented by Pengfei Wei (Beijing), Huasheng Wang (Beijing) and Bo Zhao (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "A chimeric peptide-modified SIS membrane, a preparation method therefor and an application thereof. The chimeric peptide-modified SIS membrane is used to promote the expression of ITG-Alpha3, ITG-Beta1, BMP2, RUNX2, ALP and OPN, and inhibits the growth of Streptococcus gordonii and Streptococcus sanguinis, thereby enabling th...